Read the full article here.
What the company does: Crescendo helps patients share their healthcare data with clincial-trial researchers, broadening the evidence available for new treatments
Why it's set to take off next year: With more drug companies trying to make medicines for specific populations rather than for the masses, they need more granular information from patients in the discovery phase, Breitenstein told BI. Yet it can be tough for patients to safely engae in consent-based research, she said.
"This is a company that we think is really at the forefront of doing that across the whole clinical-trial-infrastructure system," Breitenstein said.